Publication:
Effects of Different Probiotics in Indomethacin-Induced Inflammatory Bowel Disease in Rats

dc.authorscopusid15727249400
dc.authorscopusid6701427365
dc.authorscopusid25230622200
dc.authorscopusid35561472800
dc.authorscopusid23111344900
dc.contributor.authorArslan, Hatice Nilden
dc.contributor.authorGülbahar, M.Y.
dc.contributor.authorYavuz, O.
dc.contributor.authorBozkurt, A.
dc.contributor.authorGülel, G.
dc.date.accessioned2020-06-21T15:07:50Z
dc.date.available2020-06-21T15:07:50Z
dc.date.issued2009
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Arslan] Handan Hilal, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Gülbahar] Yavuz, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yavuz] Oguzhan, Department of Pharmacology and Toxicology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bozkurt] Ayhan, Department of Physiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Gülel] Goknur Terzi, Department of Food Hygiene and Technology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractIn this study, a total of 50 male Sprague-Dawley rats were used for comparative evaluation of therapeutic effects of different probiotics, VSL#3 (a combination of different probiotic bacteria), Lactobacillus acidophilus, and kefir in enterocolitis induced by subcutaneous administration of indomethacin (7.5 mg/kg) twice at 24-hour interval as the experimental inflammatory bowel disease (IBD) model. Probiotics were orally administered by orogastric gavage on a daily basis for 7 days after induction of IBD, and then rats were euthanased and tissue samples were obtained for macroscopical and histopathological investigations. At the end of the study, it was concluded that therapeutic efficiency of mix probiotic product, which contained different commercial probiotic bacterial strains, was determined in IBD, and therapeutic efficiency of kefir was also found to be notable in IBD. However, therapeutic activity of Lactobacillus acidophilus alone was not satisfactory for IBD therapy. © 2009 M. & H. Schaper GmbH.en_US
dc.identifier.doi10.2376/0341-6593-116-11
dc.identifier.endpage18en_US
dc.identifier.issn0341-6593
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-58449088420
dc.identifier.startpage11en_US
dc.identifier.urihttps://doi.org/10.2376/0341-6593-116-11
dc.identifier.volume116en_US
dc.identifier.wosWOS:000263479400002
dc.language.isoenen_US
dc.publisherM H Schaper GmbH Co Kgen_US
dc.relation.ispartofDeutsche Tierarztliche Wochenschriften_US
dc.relation.journalDeutsche Tierarztliche Wochenschriften_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInflammatory Bowel Diseaseen_US
dc.subjectKefiren_US
dc.subjectProbioticen_US
dc.subjectRaten_US
dc.titleEffects of Different Probiotics in Indomethacin-Induced Inflammatory Bowel Disease in Ratsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files